Filtros de búsqueda

Lista de obras de Martin R. Farlow

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

artículo científico publicado en 2018

2307: Resting state network profiles of Alzheimer disease and frontotemporal dementia: A preliminary examination

A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease

artículo científico publicado en 2015

A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia

artículo científico publicado en 2013

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis

artículo científico publicado en 2010

A Placebo-Controlled, Parallel Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease

scientific article published on 13 April 2020

A Review of Dementia with Lewy Bodies' Impact, Diagnostic Criteria and Treatment

artículo científico publicado en 2018

A collaborative Alzheimer disease research exchange using a community-based Helpline as a recruitment tool.

artículo científico

A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease

artículo científico publicado en 2003

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease

artículo científico publicado en 2003

A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease

artículo científico publicado en 2008

A phase 3 trial of semagacestat for treatment of Alzheimer's disease

artículo científico publicado en 2013

A phase I study of AIT-082 in healthy elderly volunteers

artículo científico publicado en 2002

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

artículo científico publicado en 2002

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

artículo científico publicado en 2000

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

artículo científico publicado en 2005

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

artículo científico publicado en 2020

A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred

artículo científico publicado en 1993

ADAM10 expression and promoter haplotype in Alzheimer's disease

artículo científico publicado en 2012

Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study

artículo científico publicado en 2016

Adipose stromal cells-secreted neuroprotective media against neuronal apoptosis

artículo científico publicado en 2009

Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis

artículo científico publicado en 2015

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition

artículo científico publicado en 2006

Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) an

artículo científico publicado en 2014

Aggressive course of disease in dementia

artículo científico publicado en 2006

Alpha2 macroglobulin and the risk of Alzheimer's disease.

artículo científico publicado en 2000

Altered default mode network connectivity in older adults with cognitive complaints and amnestic mild cognitive impairment

artículo científico publicado en 2013

Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele

Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58 ⬇️

artículo científico publicado el 1 de marzo de 1991

An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter

artículo científico publicado en 2015

Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial

artículo científico publicado en 2003

Apolipoprotein E genotype and gender influence response to tacrine therapy

artículo científico publicado en 1996

Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults

artículo científico publicado en 2016

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease

scientific article published on 02 December 2019

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

scientific article published on 01 August 2000

Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects

artículo científico publicado en 2013

Association of clusterin gene polymorphisms with late-onset Alzheimer's disease.

artículo científico publicado en 2011

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

artículo científico publicado en 2012

Association of statin use with cognitive decline in elderly African Americans

artículo científico publicado en 2007

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

Awareness of genetic risk in the Dominantly Inherited Alzheimer Network (DIAN)

scientific article published on 01 January 2020

BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease

artículo científico publicado en 2016

Beta PP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred.

artículo científico publicado en 1993

Biochemical characterization of a neuroserpin variant associated with hereditary dementia

artículo científico publicado en 2001

C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line

artículo científico publicado en 2006

Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.

artículo científico publicado en 2011

Caffeic acid phenethyl ester possesses potent cardioprotective effects in a rabbit model of acute myocardial ischemia-reperfusion injury

artículo científico publicado en 2005

Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration

artículo científico publicado en 2011

Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity

artículo científico publicado en 2008

Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury

artículo científico publicado en 2004

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

artículo científico publicado en 2015

Cerebral hypometabolism and grey matter density in MAPT intron 10 +3 mutation carriers

artículo científico publicado en 2014

Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism

article

Cerebrospinal fluid levels of amyloid beta-protein precursor are low in Gerstmann-Sträussler-Scheinker disease, Indiana kindred

scientific article published on 01 August 1994

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

artículo científico publicado en 2003

Cholesterol and APOE genotype interact to influence Alzheimer disease progression

artículo científico publicado en 2004

Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-->T change at position 2149 of the amyloid precursor protein gene

artículo científico publicado en 1994

Clinical trials in Alzheimer disease: debate on the use of placebo controls

artículo científico publicado en 1999

Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease

artículo científico publicado en 2019

Clinicopathologic correlations of soluble amyloid beta-protein precursor in cerebrospinal fluid in patients with Alzheimer disease and controls.

artículo científico publicado en 1997

Cognitive Modeling as an Interface Between Brain and Behavior: Measuring the Semantic Decline in Mild Cognitive Impairment

artículo científico

Cognitive complaints in older adults at risk for Alzheimer's disease are associated with altered resting-state networks

scientific article published on 22 December 2016

Cognitive decline and education in mild dementia

artículo científico publicado en 1998

Cognitive dysfunction and greater visit-to-visit systolic blood pressure variability

scientific article published on December 2013

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

artículo científico publicado en 2011

Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia

artículo científico publicado en 2013

Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease

artículo científico publicado en 2020

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies

article

Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults

artículo científico publicado en 2015

Connecting research discovery with care delivery in dementia: the development of the Indianapolis Discovery Network for Dementia

artículo científico publicado en 2012

Correlation of clinical features with argyrophilic grains at autopsy

scientific article published on July 2009

Corrigendum: Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis

artículo científico publicado en 2016

Decreased levels of soluble amyloid beta-protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs.

artículo científico publicado en 1994

Depressed mood in informal caregivers of individuals with mild cognitive impairment

artículo científico publicado en 2007

Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [F]Flortaucipir PET

Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics

artículo científico publicado en 2010

Disease stage in Alzheimer disease and treatment effects of rivastigmine

artículo científico publicado en 2004

Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease

artículo científico publicado en 2021

Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network

artículo científico publicado en 2015

Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene

artículo científico publicado en 2000

Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures

artículo científico publicado en 2001

Effect of BDNFVal66Met on disease markers in dominantly inherited Alzheimer's disease

scientific article published on 25 August 2018

Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study

artículo científico publicado en 2007

Effective pharmacologic management of Alzheimer's disease

artículo científico publicado en 2007

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study ⬇️

artículo científico publicado el 1 de julio de 2010

Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease

artículo científico publicado en 2006

Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.

artículo científico publicado en 1997

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity

artículo científico publicado en 2013

Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach

artículo científico publicado en 2009

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study

artículo científico publicado en 2014

Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease

artículo científico publicado en 2010

Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis

artículo científico publicado en 2010

Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine

artículo científico publicado en 2012

Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis

artículo científico publicado en 2004

Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.

artículo científico publicado en 2007

Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia ⬇️

artículo científico publicado el 15 de octubre de 2010

Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis

artículo científico publicado en 2005

Epidemiology of dementia in Nigeria: results from the Indianapolis-Ibadan study

artículo científico publicado en 2000

Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease.

artículo científico publicado en 2015

Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor

artículo científico publicado en 2015

Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response

artículo científico publicado en 2013

FASTKD2 is associated with memory and hippocampal structure in older adults

artículo científico publicado en 2014

Factors associated with the onset and persistence of post-lumbar puncture headache

artículo científico publicado en 2015

Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles

artículo científico publicado en 1994

Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments

artículo científico publicado en 1997

Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17

artículo científico publicado en 1997

Functional brain imaging in apraxia

artículo científico publicado en 1998

GDNF secreted from adipose-derived stem cells stimulates VEGF-independent angiogenesis

artículo científico publicado en 2016

GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.

artículo científico publicado en 2015

Gd-enhanced MR imaging of acute and chronic experimental demyelinating lesions

scientific article published on 01 July 1988

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families

artículo científico publicado en 2015

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

scientific article published on 09 February 2019

Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE

artículo científico publicado en 2011

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

artículo científico publicado en 2015

Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory

artículo científico publicado en 2012

Gerstmann-Sträussler-Scheinker disease and the Indiana kindred

artículo científico publicado en 1995

Gerstmann-Sträussler-Scheinker disease. I. Extending the clinical spectrum.

artículo científico publicado en 1989

High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelines

artículo científico publicado en 2013

Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity

artículo científico publicado en 2003

Human anti-prion antibodies block prion peptide fibril formation and neurotoxicity

artículo científico publicado en 2012

Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.

artículo científico publicado en 2002

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network

artículo científico publicado en 2018

IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats

artículo científico publicado en 2009

IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease.

artículo científico publicado en 2018

Identification of functional variants from whole-exome sequencing, combined with neuroimaging genetics

artículo científico publicado en 2013

Immunotherapy for Alzheimer's disease

artículo científico publicado en 2013

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer's disease: a meta-analysis

scientific article published on January 2008

Implementing innovative models of dementia care: The Healthy Aging Brain Center ⬇️

artículo científico publicado el 1 de enero de 2011

In vivo and postmortem clinicoanatomical correlations in frontotemporal dementia and parkinsonism linked to chromosome 17.

artículo científico publicado en 2008

Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure

artículo científico publicado en 2012

Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel

artículo científico publicado en 2013

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

artículo científico publicado en 2013

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors

scientific article published on 02 August 2013

Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice ⬇️

artículo científico publicado el 16 de diciembre de 2010

Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene

artículo científico publicado el 1 de abril de 1992

Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease

artículo científico publicado en 2015

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

artículo científico publicado en 2018

Medication for Alzheimer's disease and associated fall hazard: a retrospective cohort study from the Alzheimer's Disease Neuroimaging Initiative

artículo científico publicado en 2014

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

artículo científico publicado en 2004

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

artículo científico publicado en 2021

Metrifonate treatment of AD: influence of APOE genotype.

artículo científico publicado en 1999

Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons

artículo científico publicado en 2003

Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons

artículo científico publicado en 2001

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

artículo científico publicado en 2005

Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.

artículo científico publicado en 2008

Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles

artículo científico publicado el 1 de abril de 1992

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

artículo científico publicado en 1998

Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).

artículo científico publicado en 2006

NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells

artículo científico publicado en 2005

NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line

artículo científico publicado en 2002

Neurofibrillary tangles of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease share antigenic determinants with those of Alzheimer disease

artículo científico publicado en 1990

Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).

artículo científico publicado en 2016

Neuropsychological function in patients with Gerstmann-Sträussler-Scheinker disease from the Indiana kindred (F198S).

artículo científico publicado en 1997

Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy

artículo científico publicado en 2000

Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins

artículo científico publicado en 2002

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

artículo científico publicado en 2012

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography

artículo científico publicado en 2017

On the horizon: pathways for drug development in Alzheimer's disease

artículo científico publicado en 2004

Optimal management of behavioural disorders associated with dementia

artículo científico publicado en 1997

Oxaloacetate and adipose stromal cells-conditional medium synergistically protected potassium/serum deprivation-induced neuronal apoptosis

artículo científico publicado en 2016

PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).

artículo científico publicado en 1999

PET of brain prion protein amyloid in Gerstmann-Sträussler-Scheinker disease.

artículo científico publicado en 2009

Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer's disease

artículo científico publicado en 2015

Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease

artículo científico publicado en 2008

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

artículo científico publicado en 2014

Phenotypic variability in three families with valosin-containing protein mutation.

artículo científico publicado en 2012

Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.

artículo científico publicado en 2003

Polygenic risk scores in familial Alzheimer disease

artículo científico publicado en 2017

Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.

artículo científico publicado en 2018

Presymptomatic Genetic Testing with an APP Mutation in Early-Onset Alzheimer Disease: A Descriptive Study of Sibship Dynamics

artículo científico publicado en 2000

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.

artículo científico publicado en 2017

Prion protein amyloidosis

artículo científico publicado en 1996

Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred

artículo científico publicado en 1992

Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations

artículo científico publicado en 2001

Protective variant for hippocampal atrophy identified by whole exome sequencing

artículo científico publicado en 2015

Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred).

artículo científico publicado en 1996

Quality Improvement in Skilled Nursing Facilities for Residents With Alzheimer's Disease

artículo científico publicado en 2015

Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry

artículo científico publicado en 2006

RFLP analysis for APP 717 mutations associated with Alzheimer's disease ⬇️

artículo científico publicado el 1 de junio de 1993

Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease.

artículo científico publicado en 2018

Rapid detection of a pentanucleotide deletion polymorphism in the human alpha2-macroglobulin gene

artículo científico publicado en 1999

Rapid-onset dystonia-parkinsonism

artículo científico publicado en 1993

Rapid-onset dystonia-parkinsonism in a second family.

scholarly article by A Brashear et al published 1997 in Neurology

Rapid-onset dystonia-parkinsonism: a report of clinical, biochemical, and genetic studies in two families

artículo científico publicado en 1998

Rapid-onset dystonia-parkinsonism: linkage to chromosome 19q13

artículo científico publicado en 1999

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

artículo científico publicado en 2017

Rarity of the Alzheimer disease-protective APP A673T variant in the United States

artículo científico publicado en 2015

Recommendations for best practices in the treatment of Alzheimer's disease in managed care.

artículo científico publicado en 2006

Resting state network modularity along the prodromal late onset Alzheimer's disease continuum

scholarly article by Joey A Contreras et al published 22 January 2019 in NeuroImage: Clinical

Review: cholinesterase inhibitors have a modest effect on neuropsychiatric and functional outcomes in Alzheimer's disease

artículo científico publicado en 2003

Reviewing the role of donepezil in the treatment of Alzheimer's disease

artículo científico

Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research

artículo científico publicado en 2017

Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy

artículo científico publicado en 2010

Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease

artículo científico publicado en 2010

Safety and acceptability of the research lumbar puncture

artículo científico publicado en 2005

Safety and biomarker effects of solanezumab in patients with Alzheimer's disease.

artículo científico publicado en 2012

Safety and changes in plasma and cerebrospinal fluid amyloid beta after a single administration of an amyloid beta monoclonal antibody in subjects with Alzheimer disease

artículo científico publicado en 2010

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

artículo científico publicado en 2011

Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers

artículo científico publicado en 2005

Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase

artículo científico publicado en 2007

Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele

scientific article published on 01 July 2000

Single photon emission tomographic brain images in dementia of the Alzheimer type

artículo científico publicado en 1987

Spectrum of amyloid β-protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missence change at position 1924 of the APP gene ⬇️

artículo científico publicado el 31 de enero de 1992

Spheroid body myopathy revisited ⬇️

artículo científico publicado el 1 de septiembre de 1997

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors

artículo científico publicado en 2003

Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study

artículo científico publicado en 2005

Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

artículo científico publicado en 2008

Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials

artículo científico publicado en 2016

Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease

artículo científico publicado en 2012

Tau-Related White-Matter Alterations Along Spatially Selective Pathways

artículo científico publicado en 2020

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

artículo científico publicado en 2010

The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease ⬇️

artículo científico publicado el 1 de octubre de 2010

The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests

artículo científico publicado en 2016

The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model

artículo científico publicado en 2016

The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease

artículo científico publicado en 2016

The cholinergic agonist carbachol reduces intracellular beta-amyloid precursor protein in PC 12 and C6 cells

artículo científico publicado el 1 de diciembre de 1992

The cholinergic system in the pathophysiology and treatment of Alzheimer's disease

scholarly article by Harald Hampel et al published 1 July 2018 in Brain

The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells ⬇️

artículo científico publicado el 1 de enero de 1997

The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates.

artículo científico publicado en 2003

The role of choroid plexus in IVIG-induced beta-amyloid clearance

artículo científico publicado en 2014

The role of the carboxyl-terminal fragments of amyloid precursor protein in Alzheimer's disease

artículo científico publicado en 2002

The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family

artículo científico publicado en 2007

The use of memantine in dementia with Lewy bodies.

artículo científico publicado en 2005

Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers

artículo científico publicado en 2001

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease

artículo científico publicado en 1998

Validation of consensus panel diagnosis in dementia

artículo científico publicado en 2010

Variable phenotype of rapid-onset dystonia-parkinsonism

scholarly article by A Brashear et al published March 1996 in Movement Disorders

Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition

scientific article published on 26 February 2020

White matter alterations in early-stage Alzheimer's disease: A tract-specific study

scientific article published on 21 August 2019

Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment

artículo científico publicado en 2013

X-linked recessive inheritance of ataxia and adult-onset dementia: clinical features and preliminary linkage analysis

artículo científico publicado en 1987

[(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease

artículo científico publicado en 2016

gene variation and microglial activity on [C]PBR28 PET in older adults at risk for Alzheimer's disease

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda